Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1806-2026

Yeastone Broth, 11ML, 10/BOX YY3462 Recall

Yeastone Broth, 11ML, 10/BOX YY3462

FDA recall Class II

Ongoing

FDA lists this Class II recall for Yeastone Broth, 11ML, 10/BOX YY3462. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1806-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Mar 24, 2026
FDA report date
Apr 22, 2026
Quantity in commerce
2819
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

Yeastone Broth, 11ML, 10/BOX YY3462

Affected model & UDI checker

Search the exact identifiers published for Z-1806-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedYeastone Broth, 11ML, 10/BOX YY3462Check source notice848838018817
FDA code information

UDI-DI 848838018817 lots 321046, 329835, 330316, 327069, 330317, 336325, 338314, 341161, 303851, 311723

View the original FDA recall notice

Why was this product recalled?

Products may report incorrect AST results during quality control. Health consequences may include delayed response or the need to change to another antifungal agent if laboratory ignores Quality Control test result.

What actions did Remel, Inc take?

Firm began notifying consignees on March 24, 2026 via letters titled "Urgent: Medical Device Recall." Customers were informed that the affected products may report incorrect AST results during quality control. Customers were asked to notify any personnel who need to be aware of the issue. Laboratory professionals are advised to review previously reported susceptibility results generated using affected lots and assess whether retesting is appropriate. Remaining inventory of affected lots must be destroyed; these lots should not be used for any clinical laboratory testing. The firm is investigating the root cause and will implement corrective and preventive actions to prevent future recurrence.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology